Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Robak

Showing results (81-90 of 292) with videos related to

Pageof 30
Sort By:
Przeglad Lekarski|January 1, 1992
[Biological and clinical aspects of chronic granulomatous disease]T Robak, E Robak
Archivum Immunologiae Et Therapiae Experimentalis|November 4, 2000
The influence of amifostine used alone or in combination with 2-chlorodeoxyadenosine on normal and chronic myelogenous leukemia granulocyte-macrophage progenitor cells in vitroA Korycka, T Robak
Current Medicinal Chemistry|February 17, 2012
Novel and emerging drugs for systemic lupus erythematosus: mechanism of action and therapeutic activityE Robak, T Robak
Current Molecular Medicine|September 10, 2011
Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignanciesP Smolewski, T Robak
Leukemia & Lymphoma|March 1, 1996
The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro culturesT Robak, A Korycka
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|January 3, 1983
[New antineoplastic drugs of the podophyllotoxin derivative group]T Robak, A Płuzańska
Acta Haematologica Polonica|January 1, 1995
[Hypereosinophilic syndrome and eosinophilic leukemia]T Robak, E Krykowski
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|October 17, 1983
[Advances and controversies in the treatment of myeloblastic leukemia]T Robak, E Krykowski
Przeglad Lekarski|January 1, 1983
[Nephrotoxic effect of antineoplastic drugs]T Robak, J Drzewoski
Acta Haematologica Polonica|January 1, 1993
[Biological properties and clinical application of filgrastim (G-CSF)]T Robak, E Krykowski
Pageof 30

Showing results (81-90 of 292) with videos related to

Sort By:
Pageof 30
Przeglad Lekarski|January 1, 1992
[Biological and clinical aspects of chronic granulomatous disease]T Robak, E Robak
Archivum Immunologiae Et Therapiae Experimentalis|November 4, 2000
The influence of amifostine used alone or in combination with 2-chlorodeoxyadenosine on normal and chronic myelogenous leukemia granulocyte-macrophage progenitor cells in vitroA Korycka, T Robak
Current Medicinal Chemistry|February 17, 2012
Novel and emerging drugs for systemic lupus erythematosus: mechanism of action and therapeutic activityE Robak, T Robak
Current Molecular Medicine|September 10, 2011
Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignanciesP Smolewski, T Robak
Leukemia & Lymphoma|March 1, 1996
The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro culturesT Robak, A Korycka
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|January 3, 1983
[New antineoplastic drugs of the podophyllotoxin derivative group]T Robak, A Płuzańska
Acta Haematologica Polonica|January 1, 1995
[Hypereosinophilic syndrome and eosinophilic leukemia]T Robak, E Krykowski
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|October 17, 1983
[Advances and controversies in the treatment of myeloblastic leukemia]T Robak, E Krykowski
Przeglad Lekarski|January 1, 1983
[Nephrotoxic effect of antineoplastic drugs]T Robak, J Drzewoski
Acta Haematologica Polonica|January 1, 1993
[Biological properties and clinical application of filgrastim (G-CSF)]T Robak, E Krykowski
Pageof 30